Matches in SemOpenAlex for { <https://semopenalex.org/work/W2174355394> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2174355394 endingPage "378" @default.
- W2174355394 startingPage "374" @default.
- W2174355394 abstract "To evaluate the response time and safety profile of low-dose oral methotrexate pulsed therapy in idiopathic retinal periphlebitis (Eales' disease).A tertiary care center-based prospective interventional study, based on visual acuity grading, was undertaken. Twenty-one consecutive patients with idiopathic retinal periphlebitis were administered 12.5 mg methotrexate as a single oral dose, once per week for 12 weeks (cumulative dose = 150 mg). Each patient was assessed for change in visual acuity grades. Time of first therapeutic response was also noted. Drug safety was monitored by laboratory tests that included twice-weekly white blood cells and differential counts, twice-weekly platelet counts, and monthly liver function tests.Twenty-one eyes were assessed. Mean follow-up period was 6 months. All showed improvement in visual acuity grades. An excellent visual outcome (6/6 or better) was achieved in 18 (69%) eyes. Time of first therapeutic response varied from 2 to 6 weeks with a majority of eyes (80%) showing response by 4 weeks (median = 3 weeks). All the side effects of methotrexate were mild or moderate in severity and rapidly reversible on dose reduction or discontinuation. No patient had any constitutional symptoms severe enough to necessitate cessation of therapy.Low dose oral methotrexate pulse therapy (at a dose of 12.5 mg/week) is clinically effective within 4 weeks, and is associated with an acceptable safety profile." @default.
- W2174355394 created "2016-06-24" @default.
- W2174355394 creator A5034763552 @default.
- W2174355394 creator A5037895261 @default.
- W2174355394 creator A5077967875 @default.
- W2174355394 creator A5091100806 @default.
- W2174355394 date "2005-05-01" @default.
- W2174355394 modified "2023-10-16" @default.
- W2174355394 title "Response Time and Safety Profile of Pulsed Oral Methotrexate Therapy in Idiopathic Retinal Periphlebitis" @default.
- W2174355394 cites W1901298682 @default.
- W2174355394 cites W1979874662 @default.
- W2174355394 cites W1996452351 @default.
- W2174355394 cites W2020194363 @default.
- W2174355394 cites W2038919542 @default.
- W2174355394 cites W2041257525 @default.
- W2174355394 cites W2044027528 @default.
- W2174355394 cites W2046422595 @default.
- W2174355394 cites W2049279006 @default.
- W2174355394 cites W2050666511 @default.
- W2174355394 cites W2058828388 @default.
- W2174355394 cites W2060475478 @default.
- W2174355394 cites W2077367413 @default.
- W2174355394 cites W2086477757 @default.
- W2174355394 cites W2110231911 @default.
- W2174355394 cites W2133092666 @default.
- W2174355394 cites W2143284051 @default.
- W2174355394 cites W2156311549 @default.
- W2174355394 cites W2328851658 @default.
- W2174355394 cites W2342174771 @default.
- W2174355394 doi "https://doi.org/10.1177/112067210501500310" @default.
- W2174355394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15945007" @default.
- W2174355394 hasPublicationYear "2005" @default.
- W2174355394 type Work @default.
- W2174355394 sameAs 2174355394 @default.
- W2174355394 citedByCount "17" @default.
- W2174355394 countsByYear W21743553942012 @default.
- W2174355394 countsByYear W21743553942014 @default.
- W2174355394 countsByYear W21743553942016 @default.
- W2174355394 countsByYear W21743553942019 @default.
- W2174355394 countsByYear W21743553942020 @default.
- W2174355394 countsByYear W21743553942021 @default.
- W2174355394 crossrefType "journal-article" @default.
- W2174355394 hasAuthorship W2174355394A5034763552 @default.
- W2174355394 hasAuthorship W2174355394A5037895261 @default.
- W2174355394 hasAuthorship W2174355394A5077967875 @default.
- W2174355394 hasAuthorship W2174355394A5091100806 @default.
- W2174355394 hasConcept C118487528 @default.
- W2174355394 hasConcept C126322002 @default.
- W2174355394 hasConcept C141071460 @default.
- W2174355394 hasConcept C197934379 @default.
- W2174355394 hasConcept C2778257484 @default.
- W2174355394 hasConcept C2778715236 @default.
- W2174355394 hasConcept C2778903070 @default.
- W2174355394 hasConcept C2781059491 @default.
- W2174355394 hasConcept C71924100 @default.
- W2174355394 hasConceptScore W2174355394C118487528 @default.
- W2174355394 hasConceptScore W2174355394C126322002 @default.
- W2174355394 hasConceptScore W2174355394C141071460 @default.
- W2174355394 hasConceptScore W2174355394C197934379 @default.
- W2174355394 hasConceptScore W2174355394C2778257484 @default.
- W2174355394 hasConceptScore W2174355394C2778715236 @default.
- W2174355394 hasConceptScore W2174355394C2778903070 @default.
- W2174355394 hasConceptScore W2174355394C2781059491 @default.
- W2174355394 hasConceptScore W2174355394C71924100 @default.
- W2174355394 hasIssue "3" @default.
- W2174355394 hasLocation W21743553941 @default.
- W2174355394 hasLocation W21743553942 @default.
- W2174355394 hasOpenAccess W2174355394 @default.
- W2174355394 hasPrimaryLocation W21743553941 @default.
- W2174355394 hasRelatedWork W2026044934 @default.
- W2174355394 hasRelatedWork W2130235373 @default.
- W2174355394 hasRelatedWork W2386947472 @default.
- W2174355394 hasRelatedWork W2403564783 @default.
- W2174355394 hasRelatedWork W2754182833 @default.
- W2174355394 hasRelatedWork W2909708333 @default.
- W2174355394 hasRelatedWork W3139078320 @default.
- W2174355394 hasRelatedWork W3208526543 @default.
- W2174355394 hasRelatedWork W4221025366 @default.
- W2174355394 hasRelatedWork W46893447 @default.
- W2174355394 hasVolume "15" @default.
- W2174355394 isParatext "false" @default.
- W2174355394 isRetracted "false" @default.
- W2174355394 magId "2174355394" @default.
- W2174355394 workType "article" @default.